KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Non-Current Debt (2016 - 2025)

Bausch Health Companies' Non-Current Debt history spans 17 years, with the latest figure at $20.6 billion for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 8.71% year-over-year to $20.6 billion; the TTM value through Dec 2025 reached $20.6 billion, up 8.71%, while the annual FY2025 figure was $20.6 billion, 8.71% up from the prior year.
  • Non-Current Debt for Q4 2025 was $20.6 billion at Bausch Health Companies, up from $20.5 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $23.7 billion in Q1 2021 and bottomed at $18.9 billion in Q4 2024.
  • The 5-year median for Non-Current Debt is $21.2 billion (2024), against an average of $21.4 billion.
  • The largest annual shift saw Non-Current Debt fell 13.66% in 2024 before it increased 8.71% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $22.7 billion in 2021, then fell by 10.24% to $20.3 billion in 2022, then increased by 7.89% to $21.9 billion in 2023, then dropped by 13.66% to $18.9 billion in 2024, then increased by 8.71% to $20.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BHC's Non-Current Debt are $20.6 billion (Q4 2025), $20.5 billion (Q3 2025), and $20.9 billion (Q2 2025).